表紙:塞栓保護デバイスの世界市場予測(2021年~2027年)
市場調査レポート
商品コード
1025198

塞栓保護デバイスの世界市場予測(2021年~2027年)

Embolic Protection Devices Market 2021-2027

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
塞栓保護デバイスの世界市場予測(2021年~2027年)
出版日: 2021年05月11日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の塞栓保護デバイス(EPD)の市場規模は、予測期間中に8.0%のCAGRで急拡大すると予想されています。塞栓保護デバイスは、SVG(伏在静脈グラフト)、頸動脈疾患などの他、AS、PAD、急性心筋梗塞など様々な適応症に使用されます。疫学研究によると、冠動脈バイパス術(CABG)後、最初の6ヶ月以内にSVGの最大12%が閉塞し、約3.4%は2~3週目には閉塞するとされています。

複数の臨床研究が発表されており、EPDを使用することで、30日間の主要有害心血管イベント(MACE)発生率が40~50%減少しています。血管内インターベンション治療中の塞栓症はますます一般的になってきており、おそらくすべての血管内インターベンションで塞栓症物質が発生すると思われます。頸動脈、冠動脈、下肢動脈のインターベンションでは、EPDを慎重に使用して塞栓症を回避することが臨床結果の改善につながります。そのため、世界的に様々な心疾患の負担が増加している中、大きな人気を集めています。

当レポートでは、世界の塞栓保護デバイス市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と最新市場動向
  • 規則と規制

第3章 競合情勢

  • 競争のダッシュボード
  • 主要戦略分析
  • 主要企業分析
    • Abbott
    • Boston Scientific Corp.
    • Cardinal Health, Inc.
    • Medtronic plc

第4章 市場の決定要因

  • 成長要因
  • 抑制要因
  • 市場機会

第5章 市場セグメンテーション

  • 製品別の世界の塞栓保護デバイス業界市場
    • フィルター装置
    • 閉塞装置
  • アプリケーション別の世界の塞栓保護デバイス市場
    • 心血管および末梢
    • 神経血管
  • 販売チャネル別の世界の塞栓保護デバイス市場
    • 外来手術センター
    • 独立系CATHラボ
    • 病院
    • 専門心臓センター

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • Abbott
  • Boston Scientific Corp.
  • Cardinal Health, Inc.
  • Cardioptimus, LLC**
  • Cardiovascular Systems, Inc.
  • Contego Medical, LLC
  • Filterlex**
  • Innovative Cardiovascular Solutions, LLC**
  • InspireMD Inc.
  • Medtronic plc
  • NIPRO
  • Protembis GmbH**
  • Silk Road Medical
  • Terumo Corp.
  • Transverse Medical, Inc.**
  • VENUS MEDTECH
図表

LIST OF TABLES

  • 1. GLOBAL EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 2. GLOBAL FILTER DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL OCCLUSION DEVICESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 5. GLOBAL CARDIOVASCULAR & PERIPHERAL MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL NEUROVASCULAR MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 8. GLOBAL AMBULATORY SURGERY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL FREESTANDING CATH LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL SPECIALTY CARDIAC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICA EMBOLIC PROTECTION DEVICESMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 14. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET RESEARCHAND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 16. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 18. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 19. EUROPEEMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 20. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 24. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 25. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL EMBOLIC PROTECTION DEVICESMARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 2. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL EMBOLIC PROTECTION DEVICESMARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 4. GLOBAL EMBOLIC PROTECTION DEVICESMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. THE US EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. UK EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. SPAIN EMBOLIC PROTECTION DEVICESMARKET SIZE, 2020-2027 ($ MILLION)
  • 12. ROE EMBOLIC PROTECTION DEVICESMARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. REST OF ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. REST OF THE WORLD EMBOLIC PROTECTION DEVICES MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2023506

Global Embolic Protection Devices Market Size, Share & Trends Analysis Report by Product (Filter Devices and Occlusion Devices), by Application (Cardiovascular & Peripheral and Neurovascular), and by End-user (Ambulatory Surgery Centers, Freestanding CATH Labs, Hospitals, and Specialty Cardiac Centers) Forecast Period (2021-2027)

The embolic protection devices market is anticipated to grow at a rapid CAGR of 8.0% during the forecast period. Embolic protection devices are used for various indications such as SVG, carotid artery disease and others, including AS, PAD, and acute myocardial infarction. Epidemiological studies stated, up to 12% of SVGs become occluded within the first six months after coronary artery bypass graft (CABG), with approximately 3.4% occluding as early as second to third weeks. 

Multiple clinical studies published, the use of EPDs has reduced the 30-day major adverse cardiovascular events (MACE) rate by 40-50%. As embolization during endovascular interventional procedures has become increasingly prevalent, and most likely, all endovascular interventions generate embolic material. Careful use of EPDs to avoid atheroembolization during arterial interventions improves the clinical outcome in carotid, coronary and lower extremity artery interventions. Therefore, gaining significant popularity with the rising burden of various cardiac diseases globally.

The embolic protection devices market is segmented based on product, application, and end-user. Based on product, the market is segmented into filter devices and occlusion devices. Based on application, the market is categorized into cardiovascular & peripheral and neurovascular. Based on end-user, the market is fragmented into ambulatory surgery centers, freestanding CATH labs, hospitals, and specialty cardiac centers. In 2019, the cardiovascular & peripheral application segment accounted for the largest share of more than 60.0% of the global embolic protection devices market. PCI (Percutaneous Coronary Intervention) with stent placement is the most widely used revascularization procedure for SVG (Saphenous Vein Graft) lesions. Both cardiovascular & peripheral interventions with the percutaneous technique are associated with critical risk of distal embolization, which limits the clinical benefit to the patient. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiovascular & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe. Therefore, market players are offering innovative EPDs suitable for cardiovascular & peripheral interventions.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe is one of the significant markets for embolic protection devices, accounting for a large share in 2019. The rising awareness of embolic protection devices for treating various embolic complications associated with treatment procedures of CAD, PAD and valvular heart diseases coupled with improved healthcare infrastructure, various favorable guidelines and availability of technologically advanced embolic protection devices are driving the growth of the embolic protection devices market in the region.

Lastly, vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market for several years. Such inorganic initiatives will complement vendors' organic growth strategies, thereby gaining traction among end-users in the market. The market is dominated by Boston Scientific, Abbott, and Medtronic. Boston Scientific is the market leader with its innovative product line of SENTINEL Cerebral Protection System, FilterWire EZ, Sentry, and FILTERWIRE EZ Embolic Protection System for SVGs for a wide range of indications, including SVG, carotid artery disease, and others.

Research Methodology

The market study of the global embolic protection devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, research-papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Embolic Protection Devices Market Research and Analysis by Product

Global Embolic Protection Devices Market Research and Analysis by Application

Global Embolic Protection Devices Market Research and Analysis by End-user

The Report Covers

Comprehensive research methodology of the global embolic protection devices market.

This report also includes a detailed and extensive market overview with the key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global embolic protection devices market.

Insights about market determinants which are stimulating the global embolic protection devices market.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Abbott
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Boston Scientific Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Cardinal Health, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Medtronic plc
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.1. Opportunities

5. Market Segmentation

  • 5.1. Global Embolic Protection Devices Industry Market by Product
    • 5.1.1. Filter Devices
    • 5.1.2. Occlusion Devices
  • 5.2. Global Embolic Protection Devices Market by Application
    • 5.2.1. Cardiovascular & Peripheral
    • 5.2.2. Neurovascular
  • 5.3. Global Embolic Protection Devices Market by Sales Channel
    • 5.3.1. Ambulatory Surgery Centers
    • 5.3.2. Freestanding CATH Labs
    • 5.3.3. Hospitals
    • 5.3.4. Specialty Cardiac Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott
  • 7.2. Boston Scientific Corp.
  • 7.3. Cardinal Health, Inc.
  • 7.4. Cardioptimus, LLC**
  • 7.5. Cardiovascular Systems, Inc.
  • 7.6. Contego Medical, LLC
  • 7.7. Filterlex**
  • 7.8. Innovative Cardiovascular Solutions, LLC**
  • 7.9. InspireMD Inc.
  • 7.10. Medtronic plc
  • 7.11. NIPRO
  • 7.12. Protembis GmbH**
  • 7.13. Silk Road Medical
  • 7.14. Terumo Corp.
  • 7.15. Transverse Medical, Inc.**
  • 7.16. VENUS MEDTECH